Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of DP-R212 vs Components in Healthy Volunteers
NCT02814500Phase 1Unknown
- Sponsor
- Alvogen
- Start
- Jul 2016
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of amlodipine and rosuvastatin in hypertension (HTN) and dyslipidemia (2 arms), sponsored by Alvogen. Primary endpoints: Area Under the Curve to the last measurable concentration and Maximum Plasma Concentration. Status: unknown.
02
Drugs
amlodipinerosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT02814500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814500.